Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve a) the Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hemo Organic Limited has notified BSE that its Board meeting is scheduled for Friday, 29th May 2026 at 4:00 p.m. The agenda includes consideration and approval of the Audited Financial Results for the quarter and financial year ended 31st March 2026, along with the statutory auditor's report. This is a routine pre-result disclosure under SEBI (LODR) Regulations. No actual financial figures or performance commentary are included in this notice. The company's CIN is L24231GJ1992PLC018224, listed on BSE (Scrip Code: 524590). The notice is signed by Managing Director Vishwambar Kameshwar Singh.
This is a standard regulatory intimation and does not directly impact the stock. The actual financial results, when approved and disclosed, will determine any market reaction. Investors should await the audited results filing for meaningful signals.